Patents by Inventor Helene Guillemain

Helene Guillemain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of TNF
    Patent number: 8975399
    Abstract: A benzene sulphonamide compound of formula I or one of its addition salts with pharmaceutically acceptable acids, for its use in a method for treating a pathology linked to an excessive effect of TNF-alpha and for its use in a method for treating the human or animal body as a direct inhibitor of TNF-alpha.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: March 10, 2015
    Inventors: Jean-Francois Zagury, Matthieu Montes, Hadley Mouhsine, Helene Guillemain
  • TREATMENT OF A PATHOLOGY LINKED TO AN EXCESSIVE EFFECT OF TNF WITH A BENZENE SULPHONAMIDE COMPOUND
    Publication number: 20130123266
    Abstract: A benzene sulphonamide compound of formula I or one of its addition salts with pharmaceutically acceptable acids, for its use in a method for treating a pathology linked to an excessive effect of TNF-alpha and for its use in a method for treating the human or animal body as a direct inhibitor of TNF-alpha.
    Type: Application
    Filed: July 19, 2011
    Publication date: May 16, 2013
    Applicant: VAX-CONSULTING
    Inventors: Jean-François Zagury, Matthieu Montes, Hadley Mouhsine, Hélène Guillemain